Chemoinformaics analysis of ANHYDROGALACTURONIC-ACID
| Molecular Weight | 166.176 | nRot | 2 |
| Heavy Atom Molecular Weight | 156.096 | nRig | 7 |
| Exact Molecular Weight | 166.063 | nRing | 1 |
| Solubility: LogS | -2.806 | nHRing | 0 |
| Solubility: LogP | 2.333 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 24.1039 |
| nHD | 0 | BPOL | 14.3721 |
| QED | 0.624 |
| Synth | 1.201 |
| Natural Product Likeliness | -0.359 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.437 |
| MDCK | 0.0000321 |
| BBB | 0.783 |
| PPB | 0.834326 |
| VDSS | 0.796 |
| FU | 0.14247 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.953 |
| CYP2c19-inh | 0.917 |
| CYP2c19-sub | 0.647 |
| CYP2c9-inh | 0.286 |
| CYP2c9-sub | 0.874 |
| CYP2d6-inh | 0.211 |
| CYP2d6-sub | 0.874 |
| CYP3a4-inh | 0.192 |
| CYP3a4-sub | 0.281 |
| CL | 10.874 |
| T12 | 0.845 |
| hERG | 0.137 |
| Ames | 0.013 |
| ROA | 0.024 |
| SkinSen | 0.574 |
| Carcinogencity | 0.227 |
| EI | 0.986 |
| Respiratory | 0.11 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.878856 |